Thomas Palker
Department of Virus and Cell Biology
Merck Research Laboratories
Merck and Co.
Inc., WP16-101
USA
Name/email consistency: high
- Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants. Palker, T., Kiseleva, I., Johnston, K., Su, Q., Toner, T., Szymkowiak, C., Kwan, W.S., Rubin, B., Petrukhin, L., Wlochowski, J., Monteiro, J., Kraiouchkine, N., DiStefano, D., Rudenko, L., Shaw, A., Youil, R. Virus Res. (2004)
- Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles. Palker, T.J., Monteiro, J.M., Martin, M.M., Kakareka, C., Smith, J.F., Cook, J.C., Joyce, J.G., Jansen, K.U. Vaccine (2001)